List of Tables
Table 1. Global Viral Gene Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Integrating Viral Vectors
Table 3. Key Players of Non-Integrating Viral Vectors
Table 4. Global Viral Gene Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Viral Gene Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Viral Gene Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Viral Gene Therapy Market Share by Region (2020-2025)
Table 8. Global Viral Gene Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Viral Gene Therapy Market Share by Region (2026-2031)
Table 10. Viral Gene Therapy Market Trends
Table 11. Viral Gene Therapy Market Drivers
Table 12. Viral Gene Therapy Market Challenges
Table 13. Viral Gene Therapy Market Restraints
Table 14. Global Viral Gene Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Viral Gene Therapy Market Share by Players (2020-2025)
Table 16. Global Top Viral Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Gene Therapy as of 2024)
Table 17. Ranking of Global Top Viral Gene Therapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Viral Gene Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Viral Gene Therapy, Headquarters and Area Served
Table 20. Global Key Players of Viral Gene Therapy, Product and Application
Table 21. Global Key Players of Viral Gene Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Viral Gene Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Viral Gene Therapy Revenue Market Share by Type (2020-2025)
Table 25. Global Viral Gene Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Viral Gene Therapy Revenue Market Share by Type (2026-2031)
Table 27. Global Viral Gene Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Viral Gene Therapy Revenue Market Share by Application (2020-2025)
Table 29. Global Viral Gene Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Viral Gene Therapy Revenue Market Share by Application (2026-2031)
Table 31. North America Viral Gene Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Viral Gene Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Viral Gene Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Viral Gene Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Viral Gene Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Viral Gene Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Viral Gene Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Viral Gene Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Viral Gene Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Viral Gene Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Viral Gene Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Viral Gene Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Viral Gene Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Viral Gene Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Viral Gene Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Lonza Company Details
Table 47. Lonza Business Overview
Table 48. Lonza Viral Gene Therapy Product
Table 49. Lonza Revenue in Viral Gene Therapy Business (2020-2025) & (US$ Million)
Table 50. Lonza Recent Development
Table 51. Biogen Company Details
Table 52. Biogen Business Overview
Table 53. Biogen Viral Gene Therapy Product
Table 54. Biogen Revenue in Viral Gene Therapy Business (2020-2025) & (US$ Million)
Table 55. Biogen Recent Development
Table 56. Catalent Company Details
Table 57. Catalent Business Overview
Table 58. Catalent Viral Gene Therapy Product
Table 59. Catalent Revenue in Viral Gene Therapy Business (2020-2025) & (US$ Million)
Table 60. Catalent Recent Development
Table 61. Gilead Sciences Company Details
Table 62. Gilead Sciences Business Overview
Table 63. Gilead Sciences Viral Gene Therapy Product
Table 64. Gilead Sciences Revenue in Viral Gene Therapy Business (2020-2025) & (US$ Million)
Table 65. Gilead Sciences Recent Development
Table 66. Sarepta Therapeutics Company Details
Table 67. Sarepta Therapeutics Business Overview
Table 68. Sarepta Therapeutics Viral Gene Therapy Product
Table 69. Sarepta Therapeutics Revenue in Viral Gene Therapy Business (2020-2025) & (US$ Million)
Table 70. Sarepta Therapeutics Recent Development
Table 71. Novartis Company Details
Table 72. Novartis Business Overview
Table 73. Novartis Viral Gene Therapy Product
Table 74. Novartis Revenue in Viral Gene Therapy Business (2020-2025) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. Amgen Company Details
Table 77. Amgen Business Overview
Table 78. Amgen Viral Gene Therapy Product
Table 79. Amgen Revenue in Viral Gene Therapy Business (2020-2025) & (US$ Million)
Table 80. Amgen Recent Development
Table 81. Ionis Pharmaceuticals Company Details
Table 82. Ionis Pharmaceuticals Business Overview
Table 83. Ionis Pharmaceuticals Viral Gene Therapy Product
Table 84. Ionis Pharmaceuticals Revenue in Viral Gene Therapy Business (2020-2025) & (US$ Million)
Table 85. Ionis Pharmaceuticals Recent Development
Table 86. Spark Therapeutics Company Details
Table 87. Spark Therapeutics Business Overview
Table 88. Spark Therapeutics Viral Gene Therapy Product
Table 89. Spark Therapeutics Revenue in Viral Gene Therapy Business (2020-2025) & (US$ Million)
Table 90. Spark Therapeutics Recent Development
Table 91. Shanghai Sunway Biotech Company Details
Table 92. Shanghai Sunway Biotech Business Overview
Table 93. Shanghai Sunway Biotech Viral Gene Therapy Product
Table 94. Shanghai Sunway Biotech Revenue in Viral Gene Therapy Business (2020-2025) & (US$ Million)
Table 95. Shanghai Sunway Biotech Recent Development
Table 96. SIBIONO Company Details
Table 97. SIBIONO Business Overview
Table 98. SIBIONO Viral Gene Therapy Product
Table 99. SIBIONO Revenue in Viral Gene Therapy Business (2020-2025) & (US$ Million)
Table 100. SIBIONO Recent Development
Table 101. AnGes Company Details
Table 102. AnGes Business Overview
Table 103. AnGes Viral Gene Therapy Product
Table 104. AnGes Revenue in Viral Gene Therapy Business (2020-2025) & (US$ Million)
Table 105. AnGes Recent Development
Table 106. Orchard Therapeutics Company Details
Table 107. Orchard Therapeutics Business Overview
Table 108. Orchard Therapeutics Viral Gene Therapy Product
Table 109. Orchard Therapeutics Revenue in Viral Gene Therapy Business (2020-2025) & (US$ Million)
Table 110. Orchard Therapeutics Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report
List of Figures
Figure 1. Viral Gene Therapy Picture
Figure 2. Global Viral Gene Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Viral Gene Therapy Market Share by Type: 2024 VS 2031
Figure 4. Integrating Viral Vectors Features
Figure 5. Non-Integrating Viral Vectors Features
Figure 6. Global Viral Gene Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Viral Gene Therapy Market Share by Application: 2024 VS 2031
Figure 8. Metabolic Diseases Case Studies
Figure 9. Cardiovascular Diseases Case Studies
Figure 10. Muscular Diseases Case Studies
Figure 11. Hematologic Diseases Case Studies
Figure 12. Ophthalmologic Diseases Case Studies
Figure 13. Infectious Diseases Case Studies
Figure 14. Others Case Studies
Figure 15. Viral Gene Therapy Report Years Considered
Figure 16. Global Viral Gene Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Viral Gene Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Viral Gene Therapy Market Share by Region: 2024 VS 2031
Figure 19. Global Viral Gene Therapy Market Share by Players in 2024
Figure 20. Global Top Viral Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Gene Therapy as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Viral Gene Therapy Revenue in 2024
Figure 22. North America Viral Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Viral Gene Therapy Market Share by Country (2020-2031)
Figure 24. United States Viral Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Viral Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Viral Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Viral Gene Therapy Market Share by Country (2020-2031)
Figure 28. Germany Viral Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Viral Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Viral Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Viral Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Viral Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Viral Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Viral Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Viral Gene Therapy Market Share by Region (2020-2031)
Figure 36. China Viral Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Viral Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Viral Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Viral Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Viral Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Viral Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Viral Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Viral Gene Therapy Market Share by Country (2020-2031)
Figure 44. Mexico Viral Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Viral Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Viral Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Viral Gene Therapy Market Share by Country (2020-2031)
Figure 48. Turkey Viral Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Viral Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Viral Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Lonza Revenue Growth Rate in Viral Gene Therapy Business (2020-2025)
Figure 52. Biogen Revenue Growth Rate in Viral Gene Therapy Business (2020-2025)
Figure 53. Catalent Revenue Growth Rate in Viral Gene Therapy Business (2020-2025)
Figure 54. Gilead Sciences Revenue Growth Rate in Viral Gene Therapy Business (2020-2025)
Figure 55. Sarepta Therapeutics Revenue Growth Rate in Viral Gene Therapy Business (2020-2025)
Figure 56. Novartis Revenue Growth Rate in Viral Gene Therapy Business (2020-2025)
Figure 57. Amgen Revenue Growth Rate in Viral Gene Therapy Business (2020-2025)
Figure 58. Ionis Pharmaceuticals Revenue Growth Rate in Viral Gene Therapy Business (2020-2025)
Figure 59. Spark Therapeutics Revenue Growth Rate in Viral Gene Therapy Business (2020-2025)
Figure 60. Shanghai Sunway Biotech Revenue Growth Rate in Viral Gene Therapy Business (2020-2025)
Figure 61. SIBIONO Revenue Growth Rate in Viral Gene Therapy Business (2020-2025)
Figure 62. AnGes Revenue Growth Rate in Viral Gene Therapy Business (2020-2025)
Figure 63. Orchard Therapeutics Revenue Growth Rate in Viral Gene Therapy Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
